Naohiro Takeshita

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Outcomes of Curative-Intent Endoscopic Resection Combined With Adjuvant Immune Checkpoint Inhibition for Resectable Sinonasal Mucosal Melanoma.

Outcomes of Curative-Intent Endoscopic Resection Combined With Adjuvant Immune Checkpoint Inhibition for Resectable Sinonasal Mucosal Melanoma.

Journal: Head & neck

Published: July 01, 2026

Early oncologic outcomes of endoscope-assisted total maxillectomy for maxillary sinus squamous cell carcinoma: A comparative study with conventional surgery.

Early oncologic outcomes of endoscope-assisted total maxillectomy for maxillary sinus squamous cell carcinoma: A comparative study with conventional surgery.

Journal: Oral oncology

Published: February 15, 2026

A Practical Non-Robotic Surgery for Oropharyngeal Cancer in Resource-Limited Settings.

A Practical Non-Robotic Surgery for Oropharyngeal Cancer in Resource-Limited Settings.

Journal: The Laryngoscope

Published: July 05, 2025

Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.

Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.

Journal: Thyroid : official journal of the American Thyroid Association

Published: June 09, 2025

Treatment outcomes of squamous cell carcinoma of the external auditory canal and potential benefit of induction chemotherapy followed by chemoradiotherapy.

Treatment outcomes of squamous cell carcinoma of the external auditory canal and potential benefit of induction chemotherapy followed by chemoradiotherapy.

Journal: Frontiers in oncology

Published: November 19, 2024

Successful Endoscopic Management of Nasal Septum Squamous Cell Carcinoma Following Induction Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab: A Case Report.

Successful Endoscopic Management of Nasal Septum Squamous Cell Carcinoma Following Induction Chemotherapy With Paclitaxel, Carboplatin, and Cetuximab: A Case Report.

Journal: Clinical case reports

Published: October 11, 2024

Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.

Significance of imaging-detected extranodal extension in locally advanced squamous cell carcinoma of the head and neck treated with induction chemotherapy followed by chemoradiotherapy.

Journal: Oral oncology

Published: September 20, 2024

Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.

Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck.

Journal: Japanese journal of clinical oncology

Published: May 02, 2024

Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.

Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.

Journal: International journal of clinical oncology

Published: April 27, 2024

Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck.

Induction chemotherapy with paclitaxel, carboplatin, and cetuximab (PCE) followed by chemoradiotherapy for unresectable locoregional recurrence after curative surgery in patients with squamous cell carcinoma of the head and neck.

Journal: Frontiers in oncology

Published: April 21, 2024

Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE).

Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE).

Journal: Oral oncology

Published: February 15, 2024

Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma.

Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma.

Journal: Frontiers in oncology

Published: January 30, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026